Published in Neurology on May 27, 2008
Increased aortic stiffness and blood pressure in non-classic Pompe disease. J Inherit Metab Dis (2014) 1.44
Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease. J Neurol (2010) 1.38
Dolichoectasia-an evolving arterial disease. Nat Rev Neurol (2011) 1.25
Progress and problems in muscle glycogenoses. Acta Myol (2011) 1.04
Dolichoectasia diagnostic methods in a multi-ethnic, stroke-free cohort: results from the northern Manhattan study. J Neuroimaging (2013) 0.94
Non-muscle involvement in late-onset glycogenosis II. Acta Myol (2013) 0.89
Morphology and function of cerebral arteries in adults with pompe disease. JIMD Rep (2015) 0.86
Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease. Ther Clin Risk Manag (2009) 0.85
Increased arterial diameters in the posterior cerebral circulation in men with Fabry disease. PLoS One (2014) 0.82
Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report. J Vasc Interv Neurol (2014) 0.82
Dilative Arteriopathy and Leucencephalopathy as Manifestations of a Neurometabolic Disease. Open Neurol J (2015) 0.81
Research progress on vertebrobasilar dolichoectasia. Int J Med Sci (2014) 0.81
Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature. J Neurol (2013) 0.80
Glycogenosome accumulation in the arrector pili muscle in Pompe disease. Orphanet J Rare Dis (2014) 0.79
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD). J Inherit Metab Dis (2016) 0.77
The brain in late-onset glycogenosis II: a structural and functional MRI study. J Inherit Metab Dis (2013) 0.77
Altered energy state reversibly controls smooth muscle contractile function in human saphenous vein during acute hypoxia-reoxygenation: Role of glycogen, AMP-activated protein kinase, and insulin-independent glucose uptake. Biochem Pharmacol (2015) 0.77
Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts. J Neurol (2014) 0.77
Late-onset Pompe disease with complicated intracranial aneurysm: a Chinese case report. Neuropsychiatr Dis Treat (2016) 0.75
Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease. JIMD Rep (2015) 0.75
Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism. BMJ Case Rep (2015) 0.75
Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group. BMC Neurol (2015) 0.75
Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies. J Neurol (2017) 0.75
Intracranial Arterial Dolichoectasia. Front Neurol (2017) 0.75
Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med (1999) 26.42
Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging (2001) 11.18
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature (1996) 8.02
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67
EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet (2000) 4.48
The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet (2001) 4.15
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet (1997) 3.68
Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia. Intensive Care Med (2009) 3.32
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet (1993) 2.79
Mutant WD-repeat protein in triple-A syndrome. Nat Genet (2000) 2.54
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
MR imaging features of isolated cortical vein thrombosis: diagnosis and follow-up. AJNR Am J Neuroradiol (2008) 2.19
Juvenile and adult-onset acid maltase deficiency in France: genotype-phenotype correlation. Neurology (2000) 2.16
Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group. Lancet (2000) 2.07
Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease. Eur Respir J (2005) 2.04
Making diagnosis of Pompe disease at a presymptomatic stage: to treat or not to treat? Neurology (2011) 2.04
Transfer of a foreign gene into the brain using adenovirus vectors. Nat Genet (1993) 1.95
Cardiac variability in critically ill adults: influence of sepsis. Crit Care Med (2001) 1.94
Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr (1998) 1.91
Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol (2000) 1.84
Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients. J Med Genet (1995) 1.81
Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation (1999) 1.78
Prevention of autoimmune attack by targeting specific T-cell receptors in a severe combined immunodeficiency mouse model of myasthenia gravis. Ann Neurol (1999) 1.75
Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol (2001) 1.73
CpG dinucleotides are mutation hot spots in phenylketonuria. Genomics (1989) 1.70
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL. Neurology (2007) 1.70
Intra-arterial thrombus visualized on T2* gradient echo imaging in acute ischemic stroke. Cerebrovasc Dis (2005) 1.67
Clinical and molecular heterogeneity of phenylalanine hydroxylase deficiencies in France. Am J Hum Genet (1988) 1.66
High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol (2000) 1.58
Molecular genetics of phenylketonuria in Mediterranean countries: a mutation associated with partial phenylalanine hydroxylase deficiency. Am J Hum Genet (1989) 1.58
Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources. Bone Marrow Transplant (2003) 1.50
CADASIL. J Geriatr Psychiatry Neurol (2010) 1.48
Sniff nasal inspiratory pressure: what is the optimal number of sniffs? Eur Respir J (2006) 1.48
Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet (2001) 1.47
Correlation between decreased myocardial glucose phosphorylation and the DNA mutation size in myotonic dystrophy. Circulation (1994) 1.47
Zaspopathy in a large classic late-onset distal myopathy family. Brain (2007) 1.47
A gene for familial hemiplegic migraine maps to chromosome 19. Nat Genet (1993) 1.46
Exercise-induced muscle modifications: study of healthy subjects and patients with metabolic myopathies with MR imaging and P-31 spectroscopy. Radiology (1991) 1.46
Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy. Clin Nutr (2009) 1.45
Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol (2001) 1.44
GM2-gangliosidosis B1 variant: analysis of beta-hexosaminidase alpha gene abnormalities in seven patients. Am J Hum Genet (1990) 1.43
Factors predicting survival following noninvasive ventilation in amyotrophic lateral sclerosis. Eur Neurol (2008) 1.42
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Distinct muscle imaging patterns in myofibrillar myopathies. Neurology (2008) 1.41
Ventilatory assistance in patients with Duchenne muscular dystrophy. Eur Respir J (2006) 1.41
Significance of phrenic nerve electrophysiological abnormalities in Guillain-Barré syndrome. Neurology (2005) 1.41
Exercise intolerance in patients with McArdle's disease or mitochondrial myopathies. Eur J Med (1992) 1.40
Longitudinal thalamic diffusion changes after middle cerebral artery infarcts. J Neurol Neurosurg Psychiatry (2005) 1.40
Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects. J Intern Med (2013) 1.37
An unusual cause of symptomatic tension-type headache: hypertrophic branchial myopathy. Neurology (2011) 1.37
Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet (1999) 1.31
White matter changes and late-life depressive symptoms: longitudinal study. Br J Psychiatry (2007) 1.31
Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab (2007) 1.29
Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic). Am J Hum Genet (1998) 1.29
A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28
Understanding international differences in terminology for delirium and other types of acute brain dysfunction in critically ill patients. Intensive Care Med (2008) 1.28
Clinical and histologic findings in autosomal centronuclear myopathy. Neurology (2004) 1.28
Paraneoplastic anti-CV2 antibodies react with peripheral nerve and are associated with a mixed axonal and demyelinating peripheral neuropathy. Ann Neurol (2001) 1.28
Deep frontal and periventricular age related white matter changes but not basal ganglia and infratentorial hyperintensities are associated with falls: cross sectional results from the LADIS study. J Neurol Neurosurg Psychiatry (2009) 1.28
Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries. Diabetologia (2008) 1.27
New mutations of SCN4A cause a potassium-sensitive normokalemic periodic paralysis. Neurology (2004) 1.25
Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. AJNR Am J Neuroradiol (2011) 1.23
Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology (2002) 1.23
Recessive RYR1 mutations cause unusual congenital myopathy with prominent nuclear internalization and large areas of myofibrillar disorganization. Neuropathol Appl Neurobiol (2011) 1.22
LGMD2A: genotype-phenotype correlations based on a large mutational survey on the calpain 3 gene. Brain (2005) 1.22
Paramyotonia congenita: genotype to phenotype correlations in two families and report of a new mutation in the sodium channel gene. J Neurol Sci (1996) 1.21
Stem cell transplantation in a patient with late-onset nemaline myopathy and gammopathy. Neurology (2008) 1.20
EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol (2007) 1.20
Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2002) 1.20
Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis Rheum (2002) 1.18
A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J Clin Endocrinol Metab (2002) 1.18
Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology (2003) 1.18
Vascular risk factors and morphometric data in cervical artery dissection: a case-control study. J Neurol Neurosurg Psychiatry (2009) 1.16
Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement. J Clin Endocrinol Metab (1999) 1.15
Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity. EMBO J (1983) 1.13
Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases. Neurology (1988) 1.12
Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: phenotype to genotype correlations and demonstration of the predominance of two mutations. Eur J Hum Genet (1994) 1.12
99th ENMC international workshop: myotonic dystrophy: present management, future therapy. 9-11 November 2001, Naarden, The Netherlands. Neuromuscul Disord (2002) 1.12
Gaucher disease: the origins of the Ashkenazi Jewish N370S and 84GG acid beta-glucosidase mutations. Am J Hum Genet (2000) 1.09
Diffusion tensor imaging study of subcortical gray matter in cadasil. Stroke (2001) 1.08
Cognitive profile in CADASIL. J Neurol Neurosurg Psychiatry (2006) 1.08
Bilateral anorchia in infancy: occurence of micropenis and the effect of testosterone treatment. J Pediatr (2006) 1.07
Presence of ultrastructural arterial lesions in muscle and skin vessels of patients with CADASIL. Stroke (1994) 1.06
Vertebrobasilar occlusive disorders presenting as sudden sensorineural hearing loss. Laryngoscope (2004) 1.06
[Biological diagnosis of hereditary metabolic diseases. From selective screening to the mutant-cell bank]. Ann Biol Clin (Paris) (1988) 1.06
Retinal abnormalities in CADASIL: a retrospective study of 18 patients. J Neurol Neurosurg Psychiatry (2004) 1.04
Guthrie cards for detection of point mutations in phenylketonuria. Lancet (1988) 1.04
Electron microscopy in myofibrillar myopathies reveals clues to the mutated gene. Neuromuscul Disord (2008) 1.02
Chromosome 15-linked limb-girdle muscular dystrophy: clinical phenotypes in Reunion Island and French metropolitan communities. Neuromuscul Disord (1996) 1.02
Adult cases of mitochondrial DNA depletion due to TK2 defect: an expanding spectrum. Neurology (2012) 1.02
Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Genes Immun (2010) 1.01
Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. J Clin Invest (1994) 1.01
Core-rod myopathy caused by mutations in the nebulin gene. Neurology (2009) 1.01